Department of Biochemistry and Molecular Biology, Rochester, MN 55905, USA.
J Clin Immunol. 2011 Dec;31(6):1029-37. doi: 10.1007/s10875-011-9582-y. Epub 2011 Sep 10.
Monoclonal tumor plasma cells as well as non-terminally differentiated B cells having a clonal relationship to the tumor cells have been detected in the peripheral blood (PB) of some multiple myeloma (MM) patients but rarely in light chain (primary systemic) amyloidosis (AL) patients. Previously, our group found these peripheral clonotypic B cells in three AL patients. Here, we report detailed analysis of a larger cohort of AL patients to validate the prior findings and to investigate the effect of this cell population on clinical outcome. Fourteen AL patients were selected from a clinical prospective trial, and the relationship between immunoglobulin light chain variable gene (V(L)) representation in PB B cells and the clonal population in the bone marrow (BM) was investigated. A clonal relationship was not detected, and the present study provides important insights into the disparity with the earlier data, including clinical history of the patients and methodological analysis.
在一些多发性骨髓瘤(MM)患者的外周血(PB)中已经检测到单克隆肿瘤浆细胞以及与肿瘤细胞具有克隆关系的未终末分化 B 细胞,但在轻链(原发性系统性)淀粉样变性(AL)患者中很少见。以前,我们的研究小组在三名 AL 患者中发现了这些外周克隆性 B 细胞。在这里,我们报告了对更大队列的 AL 患者进行的详细分析,以验证先前的发现,并研究该细胞群对临床结果的影响。从一项临床前瞻性试验中选择了 14 名 AL 患者,并研究了 PB B 细胞中免疫球蛋白轻链可变基因(V(L))表达与骨髓(BM)中克隆群体之间的关系。未检测到克隆关系,本研究为了解与早期数据的差异提供了重要的见解,包括患者的临床病史和方法学分析。